Previous Close | 6.20 |
Open | 6.23 |
Bid | 6.33 x 1000 |
Ask | 6.38 x 1000 |
Day's Range | 6.23 - 6.37 |
52 Week Range | 3.06 - 6.76 |
Volume | |
Avg. Volume | 2,520,341 |
Market Cap | 1.472B |
Beta (5Y Monthly) | 0.43 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.13 |
Earnings Date | May 08, 2024 - May 13, 2024 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 8.38 |
In the most recent trading session, Adma Biologics (ADMA) closed at $6.27, indicating a +1.13% shift from the previous trading day.
Data from a mid-stage study show that Sage's (SAGE) experimental oral drug failed to show a statistically significant difference in treating patients with Parkinson's disease compared with a placebo.
In the most recent trading session, Adma Biologics (ADMA) closed at $6.04, indicating a -1.95% shift from the previous trading day.